These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27867013)

  • 1. Characterization of P2X4 receptor agonists and antagonists by calcium influx and radioligand binding studies.
    Abdelrahman A; Namasivayam V; Hinz S; Schiedel AC; Köse M; Burton M; El-Tayeb A; Gillard M; Bajorath J; de Ryck M; Müller CE
    Biochem Pharmacol; 2017 Feb; 125():41-54. PubMed ID: 27867013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular binding sites of positive and negative allosteric P2X4 receptor modulators.
    Weinhausen S; Nagel J; Namasivayam V; Spanier C; Abdelrahman A; Hanck T; Hausmann R; Müller CE
    Life Sci; 2022 Dec; 311(Pt A):121143. PubMed ID: 36328074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists.
    Hernandez-Olmos V; Abdelrahman A; El-Tayeb A; Freudendahl D; Weinhausen S; Müller CE
    J Med Chem; 2012 Nov; 55(22):9576-88. PubMed ID: 23075067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamazepine derivatives with P2X4 receptor-blocking activity.
    Tian M; Abdelrahman A; Weinhausen S; Hinz S; Weyer S; Dosa S; El-Tayeb A; Müller CE
    Bioorg Med Chem; 2014 Feb; 22(3):1077-88. PubMed ID: 24411477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicinal chemistry of adenosine, P2Y and P2X receptors.
    Jacobson KA; Müller CE
    Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the inhibitory effects of the benzodiazepine derivative, 5-BDBD on P2X4 purinergic receptors by two complementary methods.
    Balázs B; Dankó T; Kovács G; Köles L; Hediger MA; Zsembery A
    Cell Physiol Biochem; 2013; 32(1):11-24. PubMed ID: 23867750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels.
    Ase AR; Honson NS; Zaghdane H; Pfeifer TA; Séguéla P
    Mol Pharmacol; 2015 Apr; 87(4):606-16. PubMed ID: 25597706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Would calcium or potassium channels be responsible for cardiac arrest produced by adenosine and ATP in the right atria of Wistar rats?
    Camara H; Rodrigues JQ; Alves GA; da Silva Junior ED; Caricati-Neto A; Garcia AG; Jurkiewicz A
    Eur J Pharmacol; 2015 Dec; 768():199-206. PubMed ID: 26528795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A challenge finding P2X1 and P2X4 ligands.
    Beswick P; Wahab B; Honey MA; Paradowski M; Jiang K; Lochner M; Murrell-Lagnado RD; Thompson AJ
    Neuropharmacology; 2019 Oct; 157():107674. PubMed ID: 31238045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological differences between human and mouse P2X4 receptor explored using old and new tools.
    Fortuny-Gomez A; Fountain SJ
    Purinergic Signal; 2024 Dec; 20(6):659-667. PubMed ID: 38767821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel selective P2Y
    Ito M; Egashira SI; Yoshida K; Mineno T; Kumagai K; Kojima H; Okabe T; Nagano T; Ui M; Matsuoka I
    Life Sci; 2017 Jul; 180():137-142. PubMed ID: 28527783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Label-free versus conventional cellular assays: Functional investigations on the human histamine H
    Lieb S; Littmann T; Plank N; Felixberger J; Tanaka M; Schäfer T; Krief S; Elz S; Friedland K; Bernhardt G; Wegener J; Ozawa T; Buschauer A
    Pharmacol Res; 2016 Dec; 114():13-26. PubMed ID: 27751876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors.
    Bidula S; Nadzirin IB; Cominetti M; Hickey H; Cullum SA; Searcey M; Schmid R; Fountain SJ
    Mol Pharmacol; 2022 Jan; 101(1):33-44. PubMed ID: 34718224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unravelling purinergic regulation in the epididymis: activation of V-ATPase-dependent acidification by luminal ATP and adenosine.
    Battistone MA; Merkulova M; Park YJ; Peralta MA; Gombar F; Brown D; Breton S
    J Physiol; 2019 Apr; 597(7):1957-1973. PubMed ID: 30746715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief.
    Nagata K; Imai T; Yamashita T; Tsuda M; Tozaki-Saitoh H; Inoue K
    Mol Pain; 2009 Apr; 5():20. PubMed ID: 19389225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeling of the rat P2X4 purinoceptor: evidence for allosteric interactions of purinoceptor antagonists and monovalent cations with P2X purinoceptors.
    Michel AD; Miller KJ; Lundström K; Buell GN; Humphrey PP
    Mol Pharmacol; 1997 Mar; 51(3):524-32. PubMed ID: 9058609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2X4 subunits are part of P2X native channels in murine myenteric neurons.
    Nieto-Pescador MG; Guerrero-Alba R; Valdez-Morales E; Espinosa-Luna R; Jiménez-Vargas N; Liñan-Rico Andrómeda A; Ramos-Lomas TL; Díaz-Hernández Verónica V; Montaño LM; Barajas-López C
    Eur J Pharmacol; 2013 Jun; 709(1-3):93-102. PubMed ID: 23567069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors.
    Donnelly-Roberts DL; Namovic MT; Surber B; Vaidyanathan SX; Perez-Medrano A; Wang Y; Carroll WA; Jarvis MF
    Neuropharmacology; 2009 Jan; 56(1):223-9. PubMed ID: 18602931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages.
    Bowler JW; Bailey RJ; North RA; Surprenant A
    Br J Pharmacol; 2003 Oct; 140(3):567-75. PubMed ID: 12970084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4.
    Paalme V; Rump A; Mädo K; Teras M; Truumees B; Aitai H; Ratas K; Bourge M; Chiang CS; Ghalali A; Tordjmann T; Teras J; Boudinot P; Kanellopoulos JM; Rüütel Boudinot S
    Front Immunol; 2019; 10():2074. PubMed ID: 31552031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.